Bioorganic and Medicinal Chemistry Letters

, том 23 , издание 11 , страницы 3149-3153

Discovery of novel pyrazolo[1,5-a]pyrimidines as potent pan-Pim inhibitors by structure- and property-based drug design

Wendy Isobel Young ¹

Steven Magnuson ¹

Rich Pastor ¹

Eric Fan ²

Huiyong Hu ¹

Vickie Tsui ¹

Wei Deng ³

Jeremy Murray ¹

Micah Steffek ⁴

Heidi Ackerly Wallweber ¹

John Moffat ¹

Jason Drummond ¹

Grace Chan ¹

Eric Harstad ¹

Allen J Ebens ¹

Скрыть аффилиации авторов Показать аффилиации авторов: 4 аффилиации

Genentech, Inc, 1 DNA Way, South San Francisco, CA 94080, United States. |

Campbell Alliance, 2545 West Hillcrest Drive, Thousand Oaks, CA 94080, United States |

Merck Sharp & Dohme R&D, 2/F Building 21, 10 Jiuxianqiao Rd, Universal Business Park, Chaoyang District, Beijing 100015, China |

⁴

Novartis Institutes for Biomedical Research, 4560 Horton Street, Emeryville, CA 94608, United States |

Тип публикации: Journal Article

Дата публикации: 2013-06-01

Elsevier

Bioorganic and Medicinal Chemistry Letters

scimago Q2

wos Q2

БС2

SJR: 0.472

CiteScore: 5.1

Impact factor: 2.2

ISSN: 0960894X, 14643405

DOI: 10.1016/j.bmcl.2013.04.020

Скопировать DOI

PubMed ID: 23623490

Organic Chemistry

Drug Discovery

Biochemistry

Molecular Biology

Pharmaceutical Science

Clinical Biochemistry

Molecular Medicine

Краткое описание

Pim kinases are promising targets for the development of cancer therapeutics. Among the three Pim isoforms, Pim-2 is particularly important in multiple myeloma, yet is the most difficult to inhibit due to its high affinity for ATP. We identified compound 1 via high throughput screening. Using property-based drug design and co-crystal structures with Pim-1 kinase to guide analog design, we were able to improve potency against all three Pim isoforms including a significant 10,000-fold gain against Pim-2. Compound 17 is a novel lead with low picomolar potency on all three Pim kinase isoforms.

Найдено

Топ-30

Журналы

	2 4 6 8 10 12
Bioorganic and Medicinal Chemistry Letters	Bioorganic and Medicinal Chemistry Letters, 11, 17.46% Bioorganic and Medicinal Chemistry Letters 11 публикаций, 17.46%
Journal of Medicinal Chemistry	Journal of Medicinal Chemistry, 5, 7.94% Journal of Medicinal Chemistry 5 публикаций, 7.94%
Journal of Molecular Structure	Journal of Molecular Structure, 4, 6.35% Journal of Molecular Structure 4 публикации, 6.35%
Synthetic Communications	Synthetic Communications, 3, 4.76% Synthetic Communications 3 публикации, 4.76%
European Journal of Medicinal Chemistry	European Journal of Medicinal Chemistry, 2, 3.17% European Journal of Medicinal Chemistry 2 публикации, 3.17%
Bioorganic and Medicinal Chemistry	Bioorganic and Medicinal Chemistry, 2, 3.17% Bioorganic and Medicinal Chemistry 2 публикации, 3.17%
Journal of Heterocyclic Chemistry	Journal of Heterocyclic Chemistry, 2, 3.17% Journal of Heterocyclic Chemistry 2 публикации, 3.17%
ACS Medicinal Chemistry Letters	ACS Medicinal Chemistry Letters, 2, 3.17% ACS Medicinal Chemistry Letters 2 публикации, 3.17%
Chemistry and Biodiversity	Chemistry and Biodiversity, 2, 3.17% Chemistry and Biodiversity 2 публикации, 3.17%
Current Topics in Medicinal Chemistry	Current Topics in Medicinal Chemistry, 1, 1.59% Current Topics in Medicinal Chemistry 1 публикация, 1.59%
Current Computer-Aided Drug Design	Current Computer-Aided Drug Design, 1, 1.59% Current Computer-Aided Drug Design 1 публикация, 1.59%
Oncotarget	Oncotarget, 1, 1.59% Oncotarget 1 публикация, 1.59%
Chemical and Pharmaceutical Bulletin	Chemical and Pharmaceutical Bulletin, 1, 1.59% Chemical and Pharmaceutical Bulletin 1 публикация, 1.59%
Future Medicinal Chemistry	Future Medicinal Chemistry, 1, 1.59% Future Medicinal Chemistry 1 публикация, 1.59%
Frontiers in Chemistry	Frontiers in Chemistry, 1, 1.59% Frontiers in Chemistry 1 публикация, 1.59%
Molecules	Molecules, 1, 1.59% Molecules 1 публикация, 1.59%
Future Journal of Pharmaceutical Sciences	Future Journal of Pharmaceutical Sciences, 1, 1.59% Future Journal of Pharmaceutical Sciences 1 публикация, 1.59%
Oncogene	Oncogene, 1, 1.59% Oncogene 1 публикация, 1.59%
Blood Cancer Journal	Blood Cancer Journal, 1, 1.59% Blood Cancer Journal 1 публикация, 1.59%
Pharmaceutical Fronts	Pharmaceutical Fronts, 1, 1.59% Pharmaceutical Fronts 1 публикация, 1.59%
Bioorganic Chemistry	Bioorganic Chemistry, 1, 1.59% Bioorganic Chemistry 1 публикация, 1.59%
Drug Discovery Today	Drug Discovery Today, 1, 1.59% Drug Discovery Today 1 публикация, 1.59%
Chinese Chemical Letters	Chinese Chemical Letters, 1, 1.59% Chinese Chemical Letters 1 публикация, 1.59%
Pesticide Biochemistry and Physiology	Pesticide Biochemistry and Physiology, 1, 1.59% Pesticide Biochemistry and Physiology 1 публикация, 1.59%
ChemistrySelect	ChemistrySelect, 1, 1.59% ChemistrySelect 1 публикация, 1.59%
Angewandte Chemie	Angewandte Chemie, 1, 1.59% Angewandte Chemie 1 публикация, 1.59%
Angewandte Chemie - International Edition	Angewandte Chemie - International Edition, 1, 1.59% Angewandte Chemie - International Edition 1 публикация, 1.59%
Journal of Agricultural and Food Chemistry	Journal of Agricultural and Food Chemistry, 1, 1.59% Journal of Agricultural and Food Chemistry 1 публикация, 1.59%
Organic and Biomolecular Chemistry	Organic and Biomolecular Chemistry, 1, 1.59% Organic and Biomolecular Chemistry 1 публикация, 1.59%
Chemical Science	Chemical Science, 1, 1.59% Chemical Science 1 публикация, 1.59%
	2 4 6 8 10 12

Издатели

	5 10 15 20 25
Elsevier	Elsevier, 24, 38.1% Elsevier 24 публикации, 38.1%
Wiley	Wiley, 10, 15.87% Wiley 10 публикаций, 15.87%
American Chemical Society (ACS)	American Chemical Society (ACS), 9, 14.29% American Chemical Society (ACS) 9 публикаций, 14.29%
Taylor & Francis	Taylor & Francis, 6, 9.52% Taylor & Francis 6 публикаций, 9.52%
Springer Nature	Springer Nature, 4, 6.35% Springer Nature 4 публикации, 6.35%
Bentham Science Publishers Ltd.	Bentham Science Publishers Ltd., 2, 3.17% Bentham Science Publishers Ltd. 2 публикации, 3.17%
Royal Society of Chemistry (RSC)	Royal Society of Chemistry (RSC), 2, 3.17% Royal Society of Chemistry (RSC) 2 публикации, 3.17%
Impact Journals	Impact Journals, 1, 1.59% Impact Journals 1 публикация, 1.59%
Pharmaceutical Society of Japan	Pharmaceutical Society of Japan, 1, 1.59% Pharmaceutical Society of Japan 1 публикация, 1.59%
Frontiers Media S.A.	Frontiers Media S.A., 1, 1.59% Frontiers Media S.A. 1 публикация, 1.59%
MDPI	MDPI, 1, 1.59% MDPI 1 публикация, 1.59%
Georg Thieme Verlag KG	Georg Thieme Verlag KG, 1, 1.59% Georg Thieme Verlag KG 1 публикация, 1.59%
OOO Zhurnal "Mendeleevskie Soobshcheniya"	OOO Zhurnal "Mendeleevskie Soobshcheniya", 1, 1.59% OOO Zhurnal "Mendeleevskie Soobshcheniya" 1 публикация, 1.59%
	5 10 15 20 25

Мы не учитываем публикации, у которых нет DOI.
Статистика публикаций обновляется еженедельно.

Вы ученый?

Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.

Войти с ORCID

Метрики

Цитировать

ГОСТ |

Цитировать

ГОСТ Скопировать

Young W. I. et al. Discovery of novel pyrazolo[1,5-a]pyrimidines as potent pan-Pim inhibitors by structure- and property-based drug design // Bioorganic and Medicinal Chemistry Letters. 2013. Vol. 23. No. 11. pp. 3149-3153.

ГОСТ со всеми авторами (до 50) Скопировать

Young W. I., Magnuson S., Pastor R., Fan E., Hu H., Tsui V., Deng W., Murray J., Steffek M., Wallweber H. A., Moffat J., Drummond J., Chan G., Harstad E., Ebens A. J. Discovery of novel pyrazolo[1,5-a]pyrimidines as potent pan-Pim inhibitors by structure- and property-based drug design // Bioorganic and Medicinal Chemistry Letters. 2013. Vol. 23. No. 11. pp. 3149-3153.

RIS |

Цитировать

RIS Скопировать

TY - JOUR

DO - 10.1016/j.bmcl.2013.04.020

UR - https://doi.org/10.1016/j.bmcl.2013.04.020

TI - Discovery of novel pyrazolo[1,5-a]pyrimidines as potent pan-Pim inhibitors by structure- and property-based drug design

T2 - Bioorganic and Medicinal Chemistry Letters

AU - Young, Wendy Isobel

AU - Magnuson, Steven

AU - Pastor, Rich

AU - Fan, Eric

AU - Hu, Huiyong

AU - Tsui, Vickie

AU - Deng, Wei

AU - Murray, Jeremy

AU - Steffek, Micah

AU - Wallweber, Heidi Ackerly

AU - Moffat, John

AU - Drummond, Jason

AU - Chan, Grace

AU - Harstad, Eric

AU - Ebens, Allen J

PY - 2013

DA - 2013/06/01

PB - Elsevier

SP - 3149-3153

IS - 11

VL - 23

PMID - 23623490

SN - 0960-894X

SN - 1464-3405

ER -

BibTex |

Цитировать

BibTex (до 50 авторов) Скопировать

@article{2013_Young,

author = {Wendy Isobel Young and Steven Magnuson and Rich Pastor and Eric Fan and Huiyong Hu and Vickie Tsui and Wei Deng and Jeremy Murray and Micah Steffek and Heidi Ackerly Wallweber and John Moffat and Jason Drummond and Grace Chan and Eric Harstad and Allen J Ebens},

title = {Discovery of novel pyrazolo[1,5-a]pyrimidines as potent pan-Pim inhibitors by structure- and property-based drug design},

journal = {Bioorganic and Medicinal Chemistry Letters},

year = {2013},

volume = {23},

publisher = {Elsevier},

month = {jun},

url = {https://doi.org/10.1016/j.bmcl.2013.04.020},

number = {11},

pages = {3149--3153},

doi = {10.1016/j.bmcl.2013.04.020}

}

MLA

Цитировать

MLA Скопировать

Young, Wendy Isobel, et al. “Discovery of novel pyrazolo[1,5-a]pyrimidines as potent pan-Pim inhibitors by structure- and property-based drug design.” Bioorganic and Medicinal Chemistry Letters, vol. 23, no. 11, Jun. 2013, pp. 3149-3153. https://doi.org/10.1016/j.bmcl.2013.04.020.

Издатель

Elsevier

Журнал

Bioorganic and Medicinal Chemistry Letters

scimago Q2

wos Q2

БС2

SJR

0.472

CiteScore

5.1

Impact factor

2.2

ISSN

0960894X (Print)

14643405 (Electronic)